All stock lists
Ottobock SE & Co. KGaA (XETRA:OBCK.DE)
Germany · Delayed Price · Currency is EUR
Healthcare · Medical Instruments & Supplies
49.05-0.25 (-0.51%)
Insider Score
––Not scored
OBCK.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
OBCK.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 458.00 M | 396.00 M | 417.80 M | 382.80 M |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | 216.10 M | 189.50 M | 189.00 M | 187.80 M |
| Gross Profit | 242.00 M | 206.50 M | 228.80 M | 195.00 M |
| SG&A Expense | 137.50 M | 141.30 M | 147.90 M | 138.00 M |
| R&D Expense | 20.80 M | 19.70 M | 18.70 M | 18.70 M |
| Operating Expenses | 166.30 M | 166.10 M | 205.10 M | 163.80 M |
| Operating Income | 75.70 M | 40.40 M | 23.70 M | 31.20 M |
| Pretax Income | 69.00 M | 30.20 M | 18.30 M | 27.50 M |
| Tax Provision | 20.50 M | 11.40 M | 6.40 M | 11.50 M |
| Net Income | 48.80 M | 19.00 M | 12.00 M | 17.40 M |
| EPS (Basic) | — | 0.30 | — | 0.27 |
| EPS (Diluted) | — | 0.30 | — | 0.27 |
| Shares Outstanding | — | 63.33 M | — | 63.99 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.